Neoplasms
📧 Sign up to get email alerts when something new happens for Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy [Phase 4]
Phase 4 trial investigating mechanism of acquired immune escape in metastatic cancer progressing on checkpoint inhibitor therapy.
-
EMA approval · 2022-05-24EMA Authorised: Amifampridine SERB (amifampridine phosphate) — SERB SA
European Medicines Agency authorises amifampridine phosphate (SERB) for various neuromuscular and autoimmune conditions, with Lambert-Eaton …
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL) [Phase 1]
Phase 1 first-in-human trial of GSK3368715 in solid tumors and diffuse large B-cell lymphoma has been terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 [Phase 1]
Phase 1 trial evaluating PF-04518600 (OX40 agonist) alone and combined with PF-05082566 (4-1BB agonist) in neoplasms; completed with results…
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011) [Phase 2]
Phase 2 clinical trial update for a novel cancer therapy based on Atavistic Metamorphosis principles; current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors [Phase 1]
Phase 1 trial evaluating veliparib (ABT-888) and VX-970 in combination with cisplatin in patients with refractory solid tumors has completed…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Promoting Cancer Symptom Management in Older Adults [NA]
A completed clinical trial investigating promotion of cancer symptom management in older adults, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis [NA]
Clinical trial update on post-thrombotic syndrome and predictors of recurrence in catheter-related thrombosis; study completed with results …
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: ERANet-LAC CODE: International Care Of the Dying Evaluation
Clinical trial update for the ERANet-LAC CODE: International Care Of the Dying Evaluation; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma [Phase 1, Phase 2]
Phase 1/2a study of BAL101553 given as 48-hour infusions in adults with advanced solid tumors or recurrent glioblastoma has completed testin…
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Study of AK-01 (LY3295668) in Solid Tumors [Phase 1, Phase 2]
A two-phase clinical trial evaluating AK-01 (LY3295668) in solid tumors has completed phases 1 and 2 with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. [Phase 4]
A Phase 4 rollover trial update for everolimus in patients who completed a prior Novartis-sponsored everolimus study; results have been post…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: 111In-ch806 in Patients With Advanced Tumours Expressing the 806 Antigen [Phase 1]
Phase 1 trial update of 111In-ch806 in patients with advanced tumours expressing the 806 antigen; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1) [Phase 1]
Phase 1 trial updates for GSK3174998 alone and with pembrolizumab in advanced solid tumors (ENGAGE-1) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Intended Use Study of the BD SurePath Plus™ Pap
Clinical trial update for the intended use study of the BD SurePath Plus Pap; the study is terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Evaluating the Impact of Patient-Centered Oncology Care
Phase results for a completed oncology care trial focusing on patient-centered approaches in cancer care; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) [Phase 1]
Phase 1 study of MK-1697 in advanced solid tumors has been terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating LMB-100 alone or with nab-paclitaxel in previously treated metastatic and/or locally advanced pancreatic ductal a…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Open Label Extension In Cancer Patients [Phase 2]
Open-label extension study in cancer patients (Phase 2) completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial assessing relative bioavailability, food effect, and gastric pH modification on TAK-931 pharmacokinetics in participants with …
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of PF-06647020 in adults with advanced solid tumors completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol [Phase 4]
An extension study (Phase 4) of vemurafenib in participants with BRAF V600 mutation-positive malignancies who had prior vemurafenib exposure…
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients [Phase 1]
Phase 1 pharmacokinetic and safety study of niraparib in patients with normal or moderate hepatic impairment has completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study [Phase 4]
An extension study to provide continued bevacizumab therapy for participants who were previously enrolled in a Roche/Genentech study; Phase …